pqq cofactor has been researched along with Body Weight in 9 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metoprolol and/or PQQ were given at the onset of reperfusion to mimic clinical treatment." | 1.33 | Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. ( Cecchini, G; Karliner, JS; Li, L; Simonis, U; Teerlink, JR; Zhou, HZ; Zhu, BQ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, X | 1 |
| Yang, F | 1 |
| Huang, J | 1 |
| Jiang, S | 1 |
| Tang, Y | 1 |
| Li, J | 1 |
| Liang, C | 1 |
| Zhang, X | 1 |
| Wang, W | 1 |
| Song, Y | 1 |
| Jia, X | 1 |
| Kumar, N | 1 |
| Kar, A | 1 |
| Chaudhari, AS | 1 |
| Raghuvanshi, R | 1 |
| Kumar, GN | 1 |
| Bauerly, K | 2 |
| Harris, C | 2 |
| Chowanadisai, W | 1 |
| Graham, J | 1 |
| Havel, PJ | 1 |
| Tchaparian, E | 3 |
| Satre, M | 2 |
| Karliner, JS | 3 |
| Rucker, RB | 2 |
| Rucker, R | 1 |
| Storms, D | 2 |
| Sheets, A | 1 |
| Fascetti, A | 2 |
| Zhu, BQ | 2 |
| Zhou, HZ | 2 |
| Teerlink, JR | 2 |
| Stites, T | 1 |
| Mah, J | 1 |
| Rogers, Q | 1 |
| Simonis, U | 1 |
| Cecchini, G | 1 |
| Li, L | 1 |
9 other studies available for pqq cofactor and Body Weight
| Article | Year |
|---|---|
Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclophosphamide; Cytokines; In | 2020 |
A subchronic oral toxicity study on pyrroloquinoline quinone (PQQ) disodium salt in rats.
Topics: Administration, Oral; Animals; Body Weight; Dose-Response Relationship, Drug; Female; Male; No-Obser | 2015 |
Pyrroloquinoline quinone (PQQ) has potential to ameliorate streptozotocin-induced diabetes mellitus and oxidative stress in mice: A histopathological and biochemical study.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Insulin; Lipids; Liver; Male; | 2015 |
Genetically engineered Escherichia coli Nissle 1917 synbiotic counters fructose-induced metabolic syndrome and iron deficiency.
Topics: Animals; Body Weight; Diet; Dyslipidemias; Escherichia coli; Fructose; Genetic Engineering; Hypergly | 2017 |
Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Glucose; | 2011 |
Biochemistry: is pyrroloquinoline quinone a vitamin?
Topics: 2-Aminoadipic Acid; Aldehyde Oxidoreductases; Amino Acid Sequence; Animals; Body Weight; Diet; Evolu | 2005 |
Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.
Topics: Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests | 2004 |
Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice.
Topics: Amino Acids; Animals; Blood Glucose; Body Weight; Cells, Cultured; DNA, Mitochondrial; Fibroblasts; | 2006 |
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Body Weight; Cardiotonic Agents; Creatine Kinase | 2006 |